Drawing for EMD SERONO

USPTO serial 86950459

EMD SERONO

Reviewed by CopyMark Law Group

Reg. 5226035Status 705Renewal
Filing date
Status date
Registration date
Jun 20, 2017
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with EMD SERONO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $3,250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 1250NEW YORK, NY 10165United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases and disorders of neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncologyACTIVE—
009[ Scientific and laboratory apparatus, instruments and equipment, namely, incubators and parts and fittings therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, apparatus, instruments and equipment and parts and fittings therefor for vitrification, cultivation, cryopreservation, warming and thawing of human blastocysts, human reproductive tissue, human sperm, human oocytes or human embryos, all being for scientific or laboratory use; scientific and laboratory apparatus instruments and equipment, namely, equipment for identifying, separating, extracting and processing human sperm or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for monitoring the development, cultivation, cryopreservation, warming or thawing of human, embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for storing or preserving human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; downloadable software in the nature of a mobile application that enables users to access healthcare information ]SECTION 8 - CANCELLED—
010[ Medical apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; incubators for medical purposes; ] injection devices for pharmaceuticalsACTIVE—
016Printed instructional and teaching material in the field of healthcareACTIVE—
041Providing training about the administration of drugs; conducting conferences in the healthcare areaACTIVE—
044Providing medical information, consultancy and advisory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 20, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 14, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 14, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 14, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 11, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jun 20, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 20, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 23, 2017ALIEASSIGNED TO LIE—
Jan 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 26, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 26, 2017ALIEASSIGNED TO LIE—
Jan 26, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 26, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 26, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 13, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 13, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 24, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2016DOCKASSIGNED TO EXAMINER—
Mar 29, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance